Riskpilot← Back to searchSign inGet full accessLIDDS AB
ABBankruptOrg 5565802856Research and experimental development on natural sciences and engineering · NACE 7210Est. 19990 employees
Revenue 2024
SEK 0
EBITDA margin
—
+75% vs 2023
Equity ratio
68.1%
Financial strength
Net profit 2024
SEK -19,3M
+52% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -6,3M | +75% |
| Net profit | SEK -19,3M | +52% |
| Total assets | SEK 6,6M | -63% |
| Equity | SEK 4,5M | -68% |
| Employees | 0 | — |
Legal name
LIDDS AB
Org number
5565802856
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 november 1999
Share capital
SEK 7 233 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska direkt eller indirekt genom dotterbolag bedriva forskning, utveckling, framtagning och utlicensiering av läkemedel och därmed förenlig verksamhet.
Address
Phone
+468211686
Email
michael@amosy-partners.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 029 | 7 755 | 0 | 345 | 3 554 | 1 888 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −7 848 | −6 634 | −6 668 | −3 880 | −17 811 | −31 821 | −36 784 | −36 109 | −24 966 | −6 279 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −6 013 | −488 | −464 | −484 | −15 688 | −1 906 |
| EBIT | −7 848 | −6 634 | −6 668 | −3 880 | −23 824 | −32 309 | −37 248 | −36 593 | −40 654 | −8 185 |
| Net financials | 33 | — | −1 | 133 | −5 | −66 | −42 | −267 | 432 | −11 126 |
| Profit before tax | −7 815 | −6 634 | −6 669 | −3 748 | −23 828 | −32 346 | −37 270 | −36 860 | −40 204 | −19 312 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 815 | −6 634 | −6 669 | −3 748 | −23 828 | −32 346 | −37 270 | −36 860 | −40 204 | −19 312 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 102 346 | 121 011 | 130 811 | 163 376 | 158 090 | 54 218 | 55 593 | 25 936 | 17 672 | 6 596 |
| Equity | 99 773 | 112 520 | 127 250 | 158 517 | 152 125 | 42 807 | 48 511 | 15 348 | 13 899 | 4 490 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 573 | 8 491 | 3 560 | 4 859 | 5 965 | 11 410 | 7 082 | 10 588 | 3 773 | 2 106 |
| Total debt | 2 573 | 8 491 | 3 560 | 4 859 | 5 965 | 11 410 | 7 082 | 10 588 | 3 773 | 2 106 |
EBITDA margin
-627900000.0%
This company
15.8%
Market median
-3974050733% vs market
20152024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20152024
Return on equity
-430.1%
This company
18.4%
Market median
-2438% vs market
20152024
Net profit margin
-1931200000.0%
This company
8.1%
Market median
-23841975409% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
LJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
JF Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
RT Chief Auditor | Chief Auditor | 2022 | — | — |
MA Liquidator | Liquidator | 2026 | — | — |
EÅ Chief Auditor | Chief Auditor | 2020 | — | — |
MJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
NT Chief Auditor | Chief Auditor | 2022 | — | — |
MK Chief Auditor | Chief Auditor | 2020 | — | — |
AK Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LIDDS AB 
LIDDS Pharma ABBoard members of LIDDS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Björn Wiking | Chief Executive Officer | 0 companies |
| Lars John Anders Månsson | Chief Executive Officer | 0 companies |
| Jenni Fredrika Björnulfson | Chief Executive Officer | 0 companies |
| Roine Tobias Albing | Chief Auditor | 0 companies |
| Michael Amosy | Liquidator | 0 companies |
| Erik Åke Martin Kraft | Chief Auditor | 0 companies |
| Matthew John Lindon | Chief Executive Officer | 0 companies |
| Nina Teerés Herne | Chief Auditor | 0 companies |
| Monica Kristina Wallter | Chief Auditor | 0 companies |
| Anna Katarina Eklund | Chief Auditor | 0 companies |
| Gerd Inga-Lill Larsson | Board of Directors | 0 companies |
| Peter Stefan Rehnmark | Board of Directors | 0 companies |
| Johan Lars Fredrik Lund | Board of Directors | 0 companies |
| Sven Peter Torbjörn Browall | Board of Directors | 0 companies |
| David Olof Rikard Bejker | Board of Directors | 0 companies |
| Anders Sigvard Bjartell | Board of Directors | 0 companies |
| Max Håkan Mitteregger | Board of Directors | 0 companies |
| Pontus Göran Ottosson | Chairman | 0 companies |
| Daniel Martin Lifveredson | Chairman | 0 companies |
| Rolf Lars-Inge Sjöqvist | Board of Directors | 0 companies |
| Jan Birger Fredrik Törnell | Chairman | 0 companies |
| Bengt Ivan Viterius | Deputy Board Member | 0 companies |
| Maria Ada Eufemia Forss | Board of Directors | 0 companies |